The DTNB Knockout Huh-7 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population generated from the Huh-7 human hepatocellular carcinoma cell line. This loss-of-function model targets the DTNB gene, which encodes beta-dystrobrevin, a scaffold protein integral to the dystrophin-associated protein complex (DAPC). The polyclonal format preserves the genetic heterogeneity of the edited pool, offering flexibility for functional genomic studies without requiring clonal selection. No claims are made regarding monoclonality, biallelic disruption, or specific knockout mechanisms.
The Huh-7 host cell line was established from a differentiated hepatocellular carcinoma of a 57-year-old Japanese male. These epithelial cells are widely used in liver cancer research due to their retained hepatic functions and tumorigenicity in xenograft models. Huh-7 cells support studies of hepatitis C virus, drug metabolism, and hepatocellular signaling pathways. Their adherent morphology and stable genetic background facilitate reproducible investigations of cell?Cmatrix adhesion, migration, and cytoskeletal organization relevant to DAPC biology.
DTNB (beta-dystrobrevin) functions as a central scaffold within the DAPC, physically connecting the intracellular actin cytoskeleton to the extracellular matrix via interactions with dystrophin and the sarcoglycan?Cdystroglycan complex. It directly binds dystrophin and the syntrophin family (alpha1- and beta1-syntrophin), thereby anchoring signaling molecules such as neuronal nitric oxide synthase (nNOS) and the p85 subunit of PI3K. Mechanical stress and focal adhesion kinase activity regulate DAPC assembly, while DTNB-dependent recruitment of PI3K/AKT and MAPK pathway components modulates cell survival, proliferation, and cytoskeletal remodeling. CRISPR/Cas9-mediated disruption of DTNB destabilizes this scaffold, impairing downstream signaling node localization.
In the context of Huh-7 hepatocellular carcinoma, DTNB knockout provides a unique model to dissect DAPC functions in liver cancer cell adhesion, mechanotransduction, and invasive behavior. Loss of beta-dystrobrevin can perturb the coupling between extracellular matrix cues and intracellular signaling networks, potentially altering collective cell migration, focal adhesion dynamics, and sensitivity to anoikis. This knockout population helps to clarify whether DTNB acts as a tumor suppressor or promoter in hepatocellular carcinoma, and enables evaluation of adhesion-targeted therapeutic strategies. The model is also relevant for studying how DAPC disruption influences epithelial polarity and epithelial?Cmesenchymal transition programs.
Typical applications include western blotting and immunofluorescence to confirm DTNB loss and assess DAPC integrity, co-immunoprecipitation to probe residual protein complexes, and quantitative adhesion assays using collagen or fibronectin substrates. Functional assays such as wound healing, transwell migration, and 3D invasion can measure metastatic potential, while phospho-protein profiling and RNA-seq reveal alterations in mechanosensitive signaling pathways. The polyclonal population is suitable for high-content screening and drug sensitivity testing. For further information or to discuss custom applications, please contact Ascent Research.
